Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

PROCEDURE2 trials

Sponsors

University Hospital Tuebingen, Banner Health

Conditions

Chemotherapy-Induced ChangeGastric AdenocarcinomaPeritoneal Cancer

Phase 2

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

RecruitingNCT07178808

Banner HealthGastric Adenocarcinoma

Start: 2021-04-16End: 2031-02-22Target: 30Updated: 2026-05-01

Unknown Phase

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

University Hospital TuebingenChemotherapy-Induced Change, Peritoneal Cancer

Start: 2019-10-01End: 2022-09-30Target: 60Updated: 2019-10-10